Essex Savings Bank’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.43M | Sell |
13,631
-7
| -0.1% | -$1.51K | 0.74% | 29 |
|
|
2026
Q1 | $2.97M | Sell |
13,638
-48
| -0.4% | -$10.6K | 0.66% | 30 |
|
|
2025
Q4 | $3.13M | Sell |
13,686
-61
| -0.4% | -$13.9K | 0.68% | 28 |
|
|
2025
Q3 | $3.18M | Sell |
13,747
-230
| -2% | -$46.8K | 0.72% | 27 |
|
|
2025
Q2 | $2.59M | Buy |
13,977
+453
| +3% | +$84.2K | 0.62% | 30 |
|
|
2025
Q1 | $2.83M | Sell |
13,524
-64
| -0.5% | -$12.4K | 0.7% | 29 |
|
|
2024
Q4 | $2.41M | Sell |
13,588
-1
| -0% | -$184 | 0.6% | 31 |
|
|
2024
Q3 | $2.68M | Buy |
13,589
+885
| +7% | +$165K | 0.67% | 31 |
|
|
2024
Q2 | $2.18M | Buy |
12,704
+30
| +0.2% | +$4.97K | 0.59% | 30 |
|
|
2024
Q1 | $1.96M | Hold |
12,674
| – | – | 0.57% | 35 |
|
|
2023
Q4 | $1.96M | Sell |
12,674
-21
| -0.2% | -$3.06K | 0.57% | 35 |
|
|
2023
Q3 | $1.89M | Sell |
12,695
-500
| -4% | -$73.4K | 0.64% | 33 |
|
|
2023
Q2 | $1.78M | Buy |
13,195
+459
| +4% | +$67.3K | 0.59% | 35 |
|
|
2023
Q1 | $2.03M | Buy |
12,736
+177
| +1% | +$27.1K | 0.71% | 30 |
|
|
2022
Q4 | $2.03M | Buy |
12,559
+396
| +3% | +$60.7K | 0.71% | 28 |
|
|
2022
Q3 | $1.63M | Buy |
12,163
+809
| +7% | +$116K | 0.65% | 32 |
|
|
2022
Q2 | $1.74M | Sell |
11,354
-541
| -5% | -$82.7K | 0.66% | 29 |
|
|
2022
Q1 | $1.93M | Buy |
11,895
+2,372
| +25% | +$345K | 0.64% | 33 |
|
|
2021
Q4 | $1.29M | Sell |
9,523
-70
| -0.7% | -$8.27K | 0.44% | 55 |
|
|
2021
Q3 | $1.16M | Buy |
9,593
+368
| +4% | +$42K | 0.42% | 62 |
|
|
2021
Q2 | $1.04M | Buy |
9,225
+375
| +4% | +$42.2K | 0.4% | 67 |
|
|
2021
Q1 | $953K | Buy |
8,850
+789
| +10% | +$84.4K | 0.42% | 63 |
|
|
2020
Q4 | $864K | Sell |
8,061
-737
| -8% | -$70.8K | 0.39% | 68 |
|
|
2020
Q3 | $771K | Buy |
8,798
+1,335
| +18% | +$126K | 0.38% | 71 |
|
|
2020
Q2 | $733K | Buy |
7,463
+538
| +8% | +$47.4K | 0.44% | 61 |
|
|
2020
Q1 | $528K | Sell |
6,925
-1,395
| -17% | -$119K | 0.38% | 75 |
|
|
2019
Q4 | $737K | Sell |
8,320
-525
| -6% | -$43.6K | 0.38% | 71 |
|
|
2019
Q3 | $670K | Sell |
8,845
-3,117
| -26% | -$214K | 0.35% | 73 |
|
|
2019
Q2 | $870K | Buy |
11,962
+2,332
| +24% | +$183K | 0.31% | 72 |
|
|
2019
Q1 | $776K | Hold |
9,630
| – | – | 0.44% | 50 |
|
|
2018
Q4 | $888K | Buy |
+9,630
| New | +$847K | 0.56% | 41 |
|
Other funds holding ABBV
Essex Savings Bank's ABBV Position: Q2 2026 in Review
Essex Savings Bank reduced its AbbVie (ABBV) stake by 0.05% in Q2 2026, selling an estimated $1.51K and leaving 13,631 shares worth $3.43M. The position accounts for 0.74% of the portfolio, ranked #29.
Essex Savings Bank first reported a position in ABBV in Q4 2018 and has held it in 31 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Essex Savings Bank held 13,631 shares of AbbVie worth $3.43M as of Q2 2026.
- Essex Savings Bank sold 7 AbbVie shares in Q2 2026, an estimated $1.51K.
- AbbVie made up 0.74% of Essex Savings Bank's portfolio in Q2 2026, its #29 holding.
- Essex Savings Bank first reported a position in AbbVie in Q4 2018 and has held it in 31 quarters since.
- 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Essex Savings Bank's 13F filing for Q2 2026, filed 23 Jul 2026.